Esophagogastric Junction (EGJ)
specificA finding about one or more characteristics of esophagus and esophagogastric junction cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to carcinomas including squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, undifferentiated carcinoma, neuroendocrine cancers, and adenocarcinoma with neuroendocrine features. Sarcomas, nonepithelial cancers, and gastrointestinal stromal tumors are not staged using this staging system. (from AJCC 8th
6
Centers
6
Active Trials
—
Cancer Funding
Top Centers for Esophagogastric Junction (EGJ)(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 58.3 |
| 2 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 58.3 |
| 3 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 58.3 |
| 4 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program | 58.3 |
| 5 | Boston University Cancer CenterBoston, MA Active Research Program | 58.3 |
| 6 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 58.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →